Paradoxical prolongation of QT interval during exercise in patients with HCM: Cellular mechanisms and implications for diastolic function

Paradoxical prolongation of QT interval during exercise in patients with HCM: Cellular mechanisms and implications for diastolic function

Aims Ventricular cardiomyocytes from Hypertrophic Cardiomyopathy (HCM) patient hearts show prolonged action potential duration (APD), impaired intracellular Ca2+ homeostasis and abnormal electrical response to beta -adrenergic stimulation. We sought to determine whether this behavior is associated w...

Full description

Bibliographic Details
Main Authors:	Coppini, R, Beltrami, M, Doste, R, Bueno Orovio, A, Ferrantini, C, Vitale, G, Manuel Pioner, J, Santini, L, Argirò, A, Berteotti, M, Mori, F, Marchionni, N, Stefàno, P, Cerbai, E, Poggesi, C, Olivotto, I
Format:	Journal article
Language:	English
Published:	Oxford University Press 2022

Similar Items

Slower calcium handling balances faster cross-bridge cycling in human MYBPC3 HCM
by: Pioner, JM, et al.
Published: (2023)

Genotype-Driven Pathogenesis of Atrial Fibrillation in Hypertrophic Cardiomyopathy: The Case of Different TNNT2 Mutations
by: Josè Manuel Pioner, et al.
Published: (2022-04-01)

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
by: Coleman, JA, et al.
Published: (2024)

Remodelling of potassium currents underlies arrhythmic action potential prolongation under beta-adrenergic stimulation in hypertrophic cardiomyopathy
by: Doste, R, et al.
Published: (2022)

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
by: James A. Coleman, et al.
Published: (2024-04-01)

Pharmacological management of hypertrophic cardiomyopathy: From bench to bedside
by: Palandri, C, et al.
Published: (2022)

Electrophysiological and Contractile Effects of Disopyramide in Patients With Obstructive Hypertrophic Cardiomyopathy: a Translational Study
by: Coppini, R, et al.
Published: (2019)

Advances in Stem Cell Modeling of Dystrophin-Associated Disease: Implications for the Wider World of Dilated Cardiomyopathy
by: Josè Manuel Pioner, et al.
Published: (2020-05-01)

Electrophysiological mechanisms underlying T wave pseudonormalisation on stress ECGs in hypertrophic cardiomyopathy
by: Coleman, J, et al.
Published: (2023)

Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models
by: Cecilia Ferrantini, et al.
Published: (2017-07-01)

Ion Channel Impairment and Myofilament Ca<sup>2+</sup> Sensitization: Two Parallel Mechanisms Underlying Arrhythmogenesis in Hypertrophic Cardiomyopathy
by: Lorenzo Santini, et al.
Published: (2021-10-01)

Prolonged QT syndrome presenting as epilepsy.
by: O'Callaghan, C, et al.
Published: (1993)

Prolonged QT During Epileptic Seizures
by: J Gordon Millichap
Published: (2010-03-01)

Prolonged QT Syndrome Presenting as Epilepsy
by: J Gordon Millichap
Published: (1994-09-01)

QT Prolongation due to Graves’ Disease
by: Zain Kulairi, et al.
Published: (2017-01-01)

QT-prolongation as an indicator of complications in malaria
by: Sudhindra Rao Mananje, et al.
Published: (2017-01-01)

Effect of QT interval-prolonging drugs taken in pregnancy on the neonatal QT interval
by: Holger Michel, et al.
Published: (2023-08-01)

QT PRODACT: In Vivo QT Assay in the Conscious Dog for Assessing the Potential for QT Interval Prolongation by Human Pharmaceuticals
by: Shigeki Toyoshima, et al.
Published: (2005-01-01)

Prolonged QT dispersion is associated with pediatric syncope
by: Meki Bilici, et al.
Published: (2019-02-01)

Multifactorial QT Interval Prolongation and Takotsubo Cardiomyopathy
by: Michael Gysel, et al.
Published: (2014-01-01)

A Case of QT Prolongation Associated with Panhypopituitarism
by: Dilek Arpaci, et al.
Published: (2013-01-01)

Prolonged QT Interval in Cirrhosis: Twisting Time?
by: William Lee, et al.
Published: (2022-11-01)

Prolonged QT interval in the infants of diabetic mothers
by: Mohammad Mehdi Bagheri, et al.
Published: (2019-03-01)

Energy Drinks: Another Cause of QT Prolongation?
by: Michael D. Winniford
Published: (2019-06-01)

QT-prolonging drugs - should they ever be used?
by: A Okreglicki
Published: (2005-09-01)

Prolonged QT Interval Associated with Multiple Entities
by: Alp Alper, et al.
Published: (2021-06-01)

QT PRODACT: In Vivo QT Assay With a Conscious Monkey for Assessment of the Potential for Drug-Induced QT Interval Prolongation
by: Kentaro Ando, et al.
Published: (2005-01-01)

ATTR Gene Variants in HCM
by: Anthony J. Kanelidis, MD, et al.
Published: (2024-03-01)

Serious QT interval prolongation associated with velafaxine administration
by: Pilar Tejedor Prado, et al.
Published: (2014-09-01)

Patient safety: prescription of drugs that prolong the QT interval
by: María Jesús Hernández-Arroyo, et al.
Published: (2015-09-01)

CLINICAL SIGNIFICANCE OF DRUGINDUCED INTERVALS QT AND QTC PROLONGATION
by: N. V. Furman, et al.
Published: (2015-09-01)

QT-Interval Prolongation in the Treatment of Drug-Resistant Tuberculosis
by: A. V. Kukurika
Published: (2024-03-01)

PROLONGATION OF QT INTERVAL DURING CHEMOTHERAPY OF PULMONARY TUBERCULOSIS
by: K. I. Martynyuk, et al.
Published: (2018-07-01)

Overdose of Quetiapine—A Case Report with QT Prolongation
by: Elisabetta Bertol, et al.
Published: (2021-12-01)

QT Prolongation: Psychotropic medication versus illicit drugs
by: A. Florian, et al.
Published: (2022-06-01)

CLINICAL SIGNIFICANCE OF DRUGINDUCED INTERVALS QT AND QTC PROLONGATION
by: N. V. Furman, et al.
Published: (2015-09-01)

Drug-induced QT interval prolongation in cancer patients
by: Torben K. Becker, et al.
Published: (2011-12-01)

“Takotsubo cardiomyopathy presenting with QT prolongation: an atypical presentation.”
by: Zain Ali, et al.
Published: (2019-03-01)

PROLONGED DISPERSION OF QT AND QTC IN THALASSEMIA MAJOR PATIENTS
by: A. Kocharian, et al.
Published: (2003-08-01)

Second Degree Heart Block Associated with QT Prolongation
by: Berna Saylan Cevik, et al.
Published: (2010-02-01)